Europe Viscosupplementation Treatment for Arthritis Market was valued at USD 1.6 Billion in 2022 and is projected to reach USD 2.8 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The European viscosupplementation market is experiencing significant growth, driven by an aging population and a rising prevalence of osteoarthritis (OA). Viscosupplementation, a non-surgical treatment involving the injection of hyaluronic acid (HA) into affected joints, aims to alleviate pain and improve joint function. As of 2022, the market was valued at approximately US$4.5 billion and is projected to exceed US$11 billion by 2032, reflecting a compound annual growth rate (CAGR) of 9.37%. citeturn0search0
Regulatory frameworks in Europe classify viscosupplementation products as 'Class III' medical devices. This classification necessitates rigorous premarket approval, focusing on technical performance and safety. Manufacturers must submit comprehensive data, including laboratory testing and clinical trials, to notified bodies for evaluation. Notably, side effects are reported exclusively to these notified bodies, not directly to government agencies. citeturn0search0
The market offers various viscosupplementation products, primarily categorized based on the number of injections required: single, three, or five injections. Single-injection treatments are particularly appealing due to their convenience and minimal recovery time, allowing patients to resume daily activities promptly. citeturn0search0
Key industry players are actively contributing to market expansion through strategic product developments and collaborations. For instance, in December 2019, Fidia Farmaceutici S.p.A. introduced TRILURON, a HA-based intra-articular viscosupplement designed for knee OA treatment. Similarly, Anika Therapeutics, Inc. participated in international trade fairs in 2019, showcasing advancements in viscosupplementation therapies. citeturn0search0
Demand for viscosupplementation is further bolstered by patients seeking alternatives to knee replacement surgeries, often due to concerns about corticosteroid injections and nonsteroidal anti-inflammatory drugs (NSAIDs). The procedure's outpatient nature and quick recovery make it an attractive option for a broad demographic, including both younger and elderly patients. citeturn0search0
In summary, the European viscosupplementation market is poised for substantial growth, propelled by demographic shifts and a heightened demand for non-invasive arthritis treatments. Ongoing research, regulatory compliance, and strategic industry initiatives are essential to meet the evolving needs of patients and healthcare providers across the region.
Get an In-Depth Research Analysis of the Europe Viscosupplementation Treatment for Arthritis Market Size And Forecast [2025-2032]
Sanofi
Anika Therapeutics
Seikagaku
Zimmer
Bioventus
Ferring
Lifecore Biomedical
LG Life Sciences
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Viscosupplementation Treatment for Arthritis Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Viscosupplementation Treatment for Arthritis Market
Intra-articular Injections
Hyaluronic Acid Injections
Corticosteroid Injections
Platelet-Rich Plasma (PRP) Injections
Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers (ASCs)
Knee Osteoarthritis
Hip Osteoarthritis
Other Joints (Shoulder, Ankle, etc.)
Intra-articular
Intra-muscular
Intra-synovial
Single Injection
Multiple Injection
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Viscosupplementation Treatment for Arthritis Market Research Analysis
1. Introduction of the Europe Viscosupplementation Treatment for Arthritis Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Viscosupplementation Treatment for Arthritis Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Viscosupplementation Treatment for Arthritis Market, By Type
6. Europe Viscosupplementation Treatment for Arthritis Market, By Application
7. Europe Viscosupplementation Treatment for Arthritis Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Viscosupplementation Treatment for Arthritis Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/